AMGN vs EXEL
Amgen Inc. and Exelixis, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | AMGN | EXEL |
|---|---|---|
| Revenue | $36.8B | $2.3B |
| Net income | $7.7B | $782.6M |
| Gross margin | 67.2% | 96.4% |
| Net margin | 21.0% | 33.7% |
| Return on equity | 106.1% | 35.5% |
| Diluted EPS | $14.23 | $2.78 |
| Dividend / share | $9.66 | · |
| Payout ratio | 66.5% | · |
| Free cash flow | $8.1B | $875.8M |
| Equity | $8.7B | $2.2B |
| Net debt / equity | 5.25× | · |
| Current ratio | 1.14× | 3.56× |
| Revenue CAGR 5y | 7.6% | 18.6% |
| Profit CAGR 5y | 1.2% | 47.6% |
AMGN bills 15.8× the revenue of EXEL, and EXEL keeps more of each dollar of revenue as profit (33.7% against 21.0%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | AMGN | EXEL |
|---|---|---|
| FY2025 | $36.8B | $2.3B |
| FY2024 | $33.4B | $2.2B |
| FY2023 | $28.2B | $1.8B |
| FY2022 | $26.3B | $1.6B |
| FY2021 | $26.0B | $1.4B |
| FY2020 | $25.4B | $987.5M |
| FY2019 | $23.4B | $967.8M |
| FY2018 | $23.7B | $853.8M |
| FY2017 | $22.8B | $452.5M |
| FY2016 | $23.0B | $191.5M |
Bottom line
| Fiscal year | AMGN | EXEL |
|---|---|---|
| FY2025 | $7.7B | $782.6M |
| FY2024 | $4.1B | $521.3M |
| FY2023 | $6.7B | $207.8M |
| FY2022 | $6.6B | $182.3M |
| FY2021 | $5.9B | $231.1M |
| FY2020 | $7.3B | $111.8M |
| FY2019 | $7.8B | $321.0M |
| FY2018 | $8.4B | $690.1M |
| FY2017 | $2.0B | $154.2M |
| FY2016 | $7.7B | $-70.2M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$34,430,874,000 | AMGN |
| FY2024 | +$31,255,299,000 | AMGN |
| FY2023 | +$26,359,792,000 | AMGN |
| FY2022 | +$24,711,938,000 | AMGN |
| FY2021 | +$24,544,030,000 | AMGN |
| FY2020 | +$24,436,462,000 | AMGN |
| FY2019 | +$22,394,225,000 | AMGN |
| FY2018 | +$22,893,174,000 | AMGN |
| FY2017 | +$22,396,523,000 | AMGN |
| FY2016 | +$22,799,546,000 | AMGN |
| FY2015 | +$21,624,828,000 | AMGN |
| FY2014 | +$20,037,889,000 | AMGN |
| FY2013 | +$18,644,662,000 | AMGN |
| FY2012 | +$17,217,550,000 | AMGN |
| FY2011 | +$15,292,364,000 | AMGN |
| FY2010 | +$14,867,955,000 | AMGN |
| FY2009 | +$14,490,241,000 | AMGN |
AMGN has reported the higher revenue in every one of these 17 fiscal years. The gap has widened since the earliest year compared.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −12.7 pp | EXEL |
| FY2024 | −11.8 pp | EXEL |
| FY2023 | +12.5 pp | AMGN |
| FY2022 | +13.6 pp | AMGN |
| FY2021 | +6.6 pp | AMGN |
| FY2020 | +17.3 pp | AMGN |
| FY2019 | +0.4 pp | AMGN |
| FY2018 | −45.5 pp | EXEL |
| FY2017 | −25.4 pp | EXEL |
| FY2016 | +70.3 pp | AMGN |
| FY2015 | +467.2 pp | AMGN |
| FY2014 | +1066.3 pp | AMGN |
| FY2013 | +787.3 pp | AMGN |
| FY2012 | +331.5 pp | AMGN |
| FY2011 | −2.5 pp | EXEL |
| FY2010 | +80.6 pp | AMGN |
| FY2009 | +120.6 pp | AMGN |
The higher net margin has changed hands between AMGN and EXEL over this period.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EXEL's net margin has been more volatile than AMGN's over the 17 comparable fiscal years — 308.5 percentage points of standard deviation against 7.0.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between AMGN and EXEL over these 17 fiscal years — AMGN led in 12 and EXEL in 5.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EXEL's return on equity has been more volatile than AMGN's over the 11 comparable fiscal years — 74.1 percentage points of standard deviation against 40.1.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between AMGN and EXEL over these 11 fiscal years — AMGN led in 9 and EXEL in 2.
11 of 19 comparable fiscal years — a year missing data on either side is not counted.